Carret Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Buy |
+315,000
| New | +$391K | 0.04% | 213 |
|
|
2025
Q1 | – | Sell |
-215,000
| Closed | -$393K | – | 281 |
|
|
2024
Q4 | $393K | Buy |
215,000
+52,000
| +32% | +$95.2K | 0.04% | 210 |
|
|
2024
Q3 | $277K | Buy |
163,000
+85,400
| +110% | +$145K | 0.03% | 238 |
|
|
2024
Q2 | $106K | Buy |
77,600
+45,600
| +143% | +$62.5K | 0.01% | 269 |
|
|
2024
Q1 | $120K | Buy |
32,000
+11,000
| +52% | +$41.3K | 0.01% | 272 |
|
|
2023
Q4 | $206K | Buy |
21,000
+4,000
| +24% | +$39.2K | 0.03% | 262 |
|
|
2023
Q3 | $142K | Hold |
17,000
| – | – | 0.02% | 260 |
|
|
2023
Q2 | $226K | Hold |
17,000
| – | – | 0.03% | 242 |
|
|
2023
Q1 | $197K | Hold |
17,000
| – | – | 0.03% | 252 |
|
|
2022
Q4 | $139K | Hold |
17,000
| – | – | 0.02% | 267 |
|
|
2022
Q3 | $99K | Buy |
17,000
+5,000
| +42% | +$29.1K | 0.01% | 265 |
|
|
2022
Q2 | $53K | Buy |
+12,000
| New | +$53K | 0.01% | 273 |
|
|
2019
Q2 | – | Sell |
-10,000
| Closed | -$72K | – | 274 |
|
|
2019
Q1 | $72K | Sell |
10,000
-10,000
| -50% | -$72K | 0.01% | 258 |
|
|
2018
Q4 | $148K | Hold |
20,000
| – | – | 0.03% | 245 |
|
|
2018
Q3 | $108K | Hold |
20,000
| – | – | 0.02% | 264 |
|
|
2018
Q2 | $71K | Buy |
20,000
+3,000
| +18% | +$10.7K | 0.01% | 259 |
|
|
2018
Q1 | $35K | Buy |
+17,000
| New | +$35K | 0.01% | 257 |
|